Six underwent transurethral resection of the prostate at the completion of stone clearance.

It can be combined with transurethral resection of the prostate without prolonging hospitalization.

In the 175 patients undergoing transurethral resection of the prostate, aztreonam was compared with placebo.

Transrectal biopsy and transurethral resection of the prostate were performed for pathological diagnosis and improvement of dysuria.

Prostate cancer was detected at transurethral resection of the prostate in the remaining 8% of men.